20N BIO
20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics.
20N BIO
Social Links:
Industry:
Biotechnology
Founded:
2021-10-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.20n.bio
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API IPv6 Google Apps For Business Google GStatic Google Static Content Google Identity Platform
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
OncoOne
OncoOne is a biotech start-up dedicated to developing innovative therapeutics.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
BlueRun Ventures
BlueRun Ventures investment in Seed Round - 20n Bio
Official Site Inspections
http://www.20n.bio
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "20n Bio"
20n Bio, a peptide discovery company
Dec 17, 2021 · 20n Bio has developed a proprietary peptide discovery platform capable of screening libraries containing trillions of peptides at once, offering unparalleled potential to …See details»
20n Bio - Crunchbase Company Profile & Funding
20n Bio (pr. "twenty-n bio") is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, 20n Bio's mission is addressing unmet medical needs by …See details»
20n Bio Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for 20n Bio. Use the PitchBook Platform to explore the full profile.See details»
20n Bio - LinkedIn
20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics. Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs...See details»
20n Bio Company Profile - Office Locations, Competitors ... - Craft
May 6, 2022 · 20n Bio is a company developing the computational design of novel protein therapeutics. It specializes in generating protein drugs in silico with biophysical, functional, and …See details»
20n Bio Raises $3.3 Million in Series Seed Funding to …
Dec 17, 2021 · 20n Bio's mission is to in silico generate new protein drugs with desired properties to address unmet medical needs. Recent advances in algorithms and computing power have kindled substantial...See details»
20n Bio - Products, Competitors, Financials, Employees, …
20n Bio is a start-up focusing on biotechnology, specifically in the domain of therapeutic peptide development. The company specializes in designing and screening cyclic peptides to create …See details»
20n Bio - Funding, Financials, Valuation & Investors - Crunchbase
20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.See details»
20n Bio Raises $3.3 Million in Series Seed Funding to ... - BioSpace
MALVERN, Pa., Dec. 17, 2021 /PRNewswire/ -- 20n Bio (20n), an artificial intelligence (AI)-powered drug discovery company focusing on designing new proteins for therapeutics, has …See details»
Seed Round - 20n Bio - 2021-12-17 - Crunchbase
Dec 17, 2021 · SynBioBeta — 20n Bio Raises $3.3 Million in Series Seed Funding to Advance Computational Design of New Proteins for TherapeuticsSee details»
BIO Member Directory
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.See details»
20n Bio Raises $3.3 Million in Series Seed Funding to Advance ...
Launched in 2021 and located in Malvern PA, its mission is addressing unmet medical needs by leveraging artificial intelligence to generate protein drugs in silico with desired biophysical, …See details»
20n Bio Raises $3.3M in Seed Funding - FinSMEs
Dec 20, 2021 · 20n Bio, a Malvern, Pa.-based artificial intelligence (AI)-powered drug discovery company focusing on designing new proteins for therapeutics, raised $3.3m in seed funding. …See details»
20n Bio Appoints LIANG Shide PhD, as Vice President of …
May 6, 2022 · 20n Bio is a VC-backed start-up dedicated to the computational design of novel protein therapeutics. Launched in 2021 and located in Malvern PA, its mission is to address …See details»
AI-powered drug discovery firm 20n Bio raises $3.3M in seed …
Dec 20, 2021 · Mingfu Zhu founded 20n Bio in September. The company's mission is to use computer modeling and simulation to generate new protein drugs with desired properties to …See details»
20n Bio - Contacts, Employees, Board Members, Advisors & Alumni
20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.See details»
20n Bio Raises $3.3M to Design New Proteins for Therapeutics
Dec 17, 2021 · 20n Bio, a biotechnology startup based in Malvern, has raised $3.3 million in seed funding to design new proteins for therapeutics to meet unmet medical needs using artificial …See details»
Mingfu Zhu - CEO @ 20n Bio - Crunchbase Person Profile
Mingfu Zhu, PhD, is the founder and CEO of 20n Bio. Dr. Zhu is an expert in computational genomics. Prior to 20n, Dr. Zhu was an assistant professor at Duke University Medical Center …See details»
蓝驰家族 | AI辅助设计蛋白新药公司杭州腾砥生物（20n Bio）完 …
2021年12月17日，专注于AI辅助设计蛋白新药的杭州腾砥生物（20n Bio，简称腾砥生物）宣布完成330万美元的种子轮融资。 本轮融资由早期投资机构蓝驰创投领投。 公司将利用本次融资 …See details»
20n - Crunchbase Company Profile & Funding
Below is the map of every chemical that can be made biologically, as discovered by 20n's algorithms. An open-source platform for synthetic biology that predicts DNA edits for creating …See details»